SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
______________________
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER
 
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
 
For the month of September 2017
 
Commission File Number: 001-36349
 
MediWound Ltd.
(Translation of registrant ' s name into English)
 
42 Hayarkon Street
Yavne, 8122745 Israel
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
 
Form 20-F   Form 40-F
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
 

 
EXPLANATORY NOTE
 
On September 6, 2017, MediWound Ltd. issued a press release entitled " MediWound's NexoBrid ® Highlighted in 43 Presentations at the 17th European Burns Association Congress". A copy of this press release is attached to this Form 6-K as Exhibit 99.1.
 
2
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
MEDIWOUND LTD.
 
 
Date: September 6, 2017
By:
/s/ Sharon Malka 
 
 
 
Name: Sharon Malka
 
 
 
Title: Chief Financial and Operations Officer
 
 
3
 
EXHIBIT INDEX
 
The following exhibit is filed as part of this Form 6-K:
 
Exhibit
Description
 
 
 
4


MediWound (NASDAQ:MDWD)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more MediWound Charts.
MediWound (NASDAQ:MDWD)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more MediWound Charts.